SSX7 anticorps (Middle Region)

N° du produit ABIN2784590

Cet anticorps Lapin Polyclonal détecte spécifiquement SSX7 dans WB. Il présente une réactivité envers Humain.

Aperçu rapide pour SSX7 anticorps (Middle Region) (ABIN2784590)

Antigène: SSX7 (Synovial Sarcoma, X Breakpoint 7 (SSX7))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp SSX7 est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-SSX7 anticorps

Épitope: Middle Region

Séquence: IFPKIMPKKP AEEGNDSKGV PEASGSQNDG KHLCPPGKPS TSEKINKTSG

Homologie: Human: 100%

Attributs du produit: This is a rabbit polyclonal antibody against SSX7. It was validated on Western Blot using a cell lysate as a positive control.

Purification: Affinity Purified

Immunogène: The immunogen is a synthetic peptide directed towards the middle region of human SSX7

Information d'application

Indications d'application: Optimal working dilutions should be determined experimentally by the investigator.

Commentaires:

Antigen size: 188 AA

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freeze-thaw cycles.

Stock: -20 °C

Stockage commentaire: For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.

Détails sur SSX7

Antigène: SSX7 (Synovial Sarcoma, X Breakpoint 7 (SSX7))

Autre désignation: SSX7

Sujet: SSX7 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This gene appears not to be involved in this type of chromosome translocation.The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This gene appears not to be involved in this type of chromosome translocation.
Protein Size: 188

Poids moléculaire: 21 kDa

ID gène: 280658

NCBI Accession: NM_173358, NP_775494

UniProt: Q7RTT5